Prabhudas Lilladher's research report on Vinati Organics
Vinati Organics (VO IN) reported a topline of Rs5.53bn, reflecting 19.5% YoY and 5.4% QoQ growth. It has maintained 20% revenue growth guidance for FY25. ATBS, the company’s key product, contributed to 36% of total revenue in Q2FY25. Antioxidants segment revenue, which is expected to double in FY25 from Rs1.3bn in FY24, stood at Rs1bn in H1FY25. The company commenced commercial production of MEHQ and guaiacol in Mar’24, and samples have been sent to customers for approval. These products are expected to meaningfully contribute to revenue from FY26. Several key projects, including ATBS expansion, setting up of phenol plant, and launch of additional antioxidants, are on track and anticipated to come online in H2FY25. We expect the company's performance to improve as the ATBS expansion aligns with growing demand. Furthermore, contribution from newly launched products is expected to rise.
Outlook
The stock currently trades at 41x FY27 EPS. We maintain ‘Accumulate’ rating on the stock, with a revised target price of Rs 2,055, valuing it at 48x FY27/FY26E.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.